V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002427 | 230004871 | 1.55 | 71.6 | null | 2019-08-25 | 2019-09-16 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100108323 |
| 230002428 | 230004872 | null | null | Palliative (P) | null | 2019-10-24 | Carboplatin AUC 6 - 10 | 02 | Y | CARBOPLATIN | 100900808 |
| 230002431 | 230004874 | 1.68 | 55 | null | 2019-10-03 | 2019-10-28 | null | null | null | PEMBROLIZUMAB | 100286315 |
| 230002432 | 230004875 | 1.64 | 47.9 | null | null | 2020-10-11 | CISPLATIN + ETOPOSIDE | 02 | null | TRIAL UNSPECIFIED | 100148290 |
| 230002434 | 230004876 | 1.65 | 55.4 | null | 2019-10-19 | 2019-10-28 | null | null | null | CARBOPLATIN | 100179872 |
| 230002436 | 230004878 | null | null | null | 2019-01-16 | 2019-01-16 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101070313 |
| 230002438 | 230004880 | 1.6 | 62.7 | null | 2019-09-08 | 2019-09-11 | Rucaparib | 02 | null | RUCAPARIB | 100242657 |
| 230002443 | 230004885 | 1.55 | 58.8 | null | 2019-07-03 | 2019-10-24 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100258578 |
| 230002446 | 230004888 | null | null | null | 2019-01-31 | 2019-02-23 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100751409 |
| 230002448 | 230004890 | 1.69 | 72 | null | null | 2016-12-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100086999 |
| 230002450 | 230004891 | 1.68 | 75 | Palliative (P) | 2019-09-24 | 2019-11-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100880079 |
| 230002454 | 230004894 | null | null | Palliative (P) | 2020-10-23 | 2020-10-26 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100423644 |
| 230002455 | 230004895 | 1.5 | null | Palliative (P) | 2020-10-12 | 2021-07-18 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | null | CAPECITABINE + OXALIPLATIN | 100663024 |
| 230002457 | 230004897 | 1.63 | 85 | null | 2017-10-26 | 2017-10-26 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100471205 |
| 230002458 | 230004898 | 1.54 | 54.5 | Neo-adjuvant (N) | 2020-03-21 | 2020-04-06 | Olaparib | 02 | N | OLAPARIB | 101061713 |
| 230002463 | 230004903 | 1.76 | 65.4 | Neo-adjuvant (N) | 2020-05-21 | 2021-10-02 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101083263 |
| 230002465 | 230004905 | 1.62 | 52.4 | null | 2019-09-26 | 2019-09-28 | Carboplatin + Liposomal Doxorubicin | 01 | null | LIPOSOMAL DOXORUBICIN | 100654335 |
| 230002466 | 230004906 | 1.62 | 70.6 | null | 2017-01-10 | 2017-11-20 | Liposomal Doxorubicin 50mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101067349 |
| 230002467 | 230004907 | 1.65 | 55.3 | null | 2020-05-16 | 2020-05-17 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101109514 |
| 230002468 | 230004908 | 1.59 | 56 | null | 2019-05-31 | 2019-06-22 | null | null | null | DOXORUBICIN | 101328624 |
| 230002469 | 230004909 | 1.62 | 65.4 | null | 2016-05-05 | 2016-05-21 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100253053 |
| 230002470 | 230004910 | 1.54 | 74.6 | null | null | 2019-06-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100266774 |
| 230002471 | 230004911 | 1.6 | 73.3 | null | 2021-01-07 | 2021-01-07 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100067205 |
| 230002472 | 230004912 | 1.67 | 44.8 | Adjuvant (A) | 2019-12-16 | 2019-12-29 | Olaparib | 02 | N | OLAPARIB | 100269328 |
| 230002473 | 230004913 | null | null | null | 2017-03-19 | 2017-03-28 | null | null | null | PACLITAXEL | 101806295 |
| 230002474 | 230004914 | null | null | null | 2018-11-12 | 2018-11-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100335249 |
| 230002475 | 230004915 | 1.59 | 65 | Neo-adjuvant (N) | 2020-04-20 | 2020-05-14 | Niraparib | 02 | N | NIRAPARIB | 101761464 |
| 230002476 | 230004916 | 1.73 | 63.8 | Palliative (P) | 2017-07-24 | 2017-07-26 | ICON8B TRIAL | 01 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101211855 |
| 230002477 | 230004917 | null | null | null | 2019-07-15 | 2019-07-27 | null | null | null | OLAPARIB | 100649742 |
| 230002478 | 230004918 | 1.62 | 115.7 | null | 2021-10-19 | 2022-02-20 | null | 02 | null | CISPLATIN | 100923787 |
| 230002479 | 230004919 | null | null | null | 2021-01-07 | 2021-04-22 | null | 01 | null | PEMBROLIZUMAB | 100934528 |
| 230002480 | 230004920 | null | null | null | 2020-06-15 | 2020-06-19 | Bevacizumab | 02 | null | BEVACIZUMAB | 101124067 |
| 230002481 | 230004921 | 1.62 | 104 | Palliative (P) | 2020-08-17 | 2020-10-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100793309 |
| 230002482 | 230004922 | null | null | null | 2018-07-28 | 2018-08-03 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100170870 |
| 230002483 | 230004923 | 1.72 | 57 | null | 2016-07-06 | 2017-05-03 | Niraparib | 02 | null | NIRAPARIB | 101660639 |
| 230002484 | 230004924 | 1.58 | 91.8 | null | 2016-11-25 | 2016-11-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101190704 |
| 230002487 | 230004927 | 1.61 | 133.2 | null | null | 2019-03-22 | Cisplatin | 02 | null | TRIAL UNSPECIFIED | 101429779 |
| 230002488 | 230004928 | 1.59 | 56 | null | 2019-04-08 | 2019-05-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101568009 |
| 230002489 | 230004929 | null | null | Adjuvant (A) | null | 2019-05-04 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101859394 |
| 230002490 | 230004930 | 1.68 | 91.5 | null | 2018-08-16 | 2018-08-16 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100598119 |
| 230002492 | 230004932 | 1.64 | 82 | null | null | 2020-06-25 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101362277 |
| 230002494 | 230004934 | null | null | null | 2020-02-05 | 2020-02-06 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101499860 |
| 230002495 | 230004935 | 1.6 | 55.9 | Curative (C) | 2017-03-29 | 2017-04-07 | null | N | N | CISPLATIN + ETOPOSIDE | 100958318 |
| 230000127 | 230004938 | null | null | null | 2019-11-20 | 2019-11-24 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101739748 |
| 230000317 | 230004940 | null | 75.3 | Palliative (P) | 2019-09-30 | 2019-12-09 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101509316 |
| 230000346 | 230004941 | null | null | null | 2016-12-03 | 2016-12-12 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101512272 |
| 230000353 | 230004942 | null | null | Palliative (P) | null | 2019-03-02 | Niraparib | 02 | N | NIRAPARIB | 101630688 |
| 230000356 | 230004943 | null | null | null | 2019-05-15 | 2019-11-01 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101380909 |
| 230000394 | 230004944 | 1.5 | 70.4 | null | 2019-08-20 | 2019-08-29 | Bevacizumab 7.5mg/kg | 02 | null | PEMBROLIZUMAB | 100919016 |
| 230000396 | 230004945 | 1.58 | 84.9 | Palliative (P) | 2019-08-26 | 2019-09-21 | null | null | N | ETOPOSIDE | 100000787 |